Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Revue Medicale Suisse|July 19, 2016
[When to refer patients for oncogenetic counseling?]Valeria Viassolo, Pierre O Chappuis
Dermatology Practical & Conceptual|August 9, 2024
Prevalence of CDKN2A, CDK4, POT1, BAP1, MITF, ATM, and TERT Pathogenic Variants in a Single-Center Retrospective Series of Patients With Melanoma and Personal or Family History Suggestive of Genetic PredispositionGiada Ferrara, Salvatore Paiella, Giulio Settanni, et al.
Prenatal Diagnosis|September 19, 2006
Fetal aortic root dilation: a prenatal feature of the Loeys-Dietz syndromeValeria Viassolo, Mario Lituania, Maurizio Marasini, et al.
Plos One|November 22, 2014
Clinical application of micronucleus test: a case-control study on the prediction of breast cancer risk/susceptibilityClaudia Bolognesi, Paolo Bruzzi, Viviana Gismondi, et al.
Breast Cancer Research : BCR|June 22, 2019
Machine learning techniques for personalized breast cancer risk prediction: comparison with the BCRAT and BOADICEA modelsChang Ming, Valeria Viassolo, Nicole Probst-Hensch, et al.
British Journal of Cancer|June 23, 2020
Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendationsChang Ming, Valeria Viassolo, Nicole Probst-Hensch, et al.
Breast Cancer Research and Treatment|February 13, 2014
Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based studyAurélie Ayme, Valeria Viassolo, Elisabetta Rapiti, et al.
Cancer Medicine|February 18, 2017
Opportunities for improving triple-negative breast cancer outcomes: results of a population-based studyElisabetta Rapiti, Kim Pinaud, Pierre O Chappuis, et al.
Cancers|August 29, 2024
Deep Neural Network Integrated into Network-Based Stratification (D3NS): A Method to Uncover Cancer Subtypes from Somatic MutationsMatteo Valerio, Alessandro Inno, Alberto Zambelli, et al.
Cancer Cytopathology|April 28, 2026
Exploring alternatives to tumor tissue for BRCA1/2 next-generation sequencing testing in high-grade serous ovarian cancer: A 34-case series of malignant ascitesChiara Pighi, Giulio Settanni, Marta Angelini, et al.
Pageof 3